CTC Bio received approval for Phase 1 clinical trial of 'CDFF0511' for the development of film-type Baraclude

On July 29, according to the Ministry of Food and Drug Safety, CTC Bio received approval for Phase 1 clinical trial of 'CDFF0511'. This clinical trial is for the development of film-type Baraclude from tablet form Baraclude.

The patent of Baraclude whose annual revenues are more than 100 billion won, expires in October next year. As a result, about 40 generic drugs already received approval. H...